Floatz logo

Sonovue

Cold Virus

Thunder Bay Regional Health Research InstituteEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cold Virus cohort.

Asset / SponsorPhaseRating
Helium
Thunder Bay Regional Health Research Institute
Early Phase 1C
PERFLUTREN
Thunder Bay Regional Health Research Institute
Early Phase 1C
XENON
Thunder Bay Regional Health Research Institute
Early Phase 1C

Same molecule, other indications

Sonovue is also rated in:

renal cell carcinomaDormant
BB
Indicative ·
67 / 100
View asset →
carotid stenosisDormant
B
Indicative ·
62 / 100
View asset →
stroke disorderDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →